Area of research
Oncology · Obstetrics and Gynecology
Research interest
Research interests include HER2/EGFR in Cancer Research, Uterine Myomas and Treatments, RNA modifications and cancer, and Cancer Cells and Metastasis.
Role of RPL39 in Metaplastic Breast Cancer
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance